Progressive Multifocal Leukoencephalopathy in the Biologic Era: Implications for Practice

Supplement Editor:
Leonard Calabrese, DO

Contents

Introduction: Progressive multifocal leukoencephalopathy in the biologic era
Leonard Calabrese, DO

History and current concepts in the pathogenesis of PML
Eugene O. Major, PhD

The clinical features of PML
Joseph R. Berger, MD

Pharmacovigilance and PML in the oncology setting
Charles L. Bennett, MD, PhD, MPP

Multiple sclerosis, natalizumab, and PML: Helping patients decide
Richard R. Rudick, MD

HIV-associated PML: Changing epidemiology and clinical approach
David M. Simpson, MD, FRCP, MRCPI

PML and rheumatology: The contribution of disease and drugs
Eamonn S. Molloy, MD, MS, MRCPI

Advances in the management of PML: Focus on natalizumab
Robert Fox, MD

A rational approach to PML for the clinician
Leonard Calabrese, DO